Cyclophosphamide (Carbostatin, Endoxan and other brands) — Patient Guide (UK)

Cyclophosphamide is a powerful chemotherapy medicine used to treat a range of serious illnesses, including some types of cancer and severe immune system conditions. Because it can affect healthy cells and can cause significant side effects, it is used under specialist supervision and with careful monitoring.

Quick product information

• Generic name: Cyclophosphamide
• Common brands in the UK: e.g., Endoxan, Carbostatin (brand names can vary)
• Type: Chemotherapy / immunosuppressant (alkylating agent)
• Availability: Prescription-only medicine in the UK
• How it may be given: tablets or injections/infusions (route depends on indication and regimen)
• Important note: Your care team will tailor the dose, schedule, and monitoring plan to your condition, blood tests, and kidney/liver function.

What Cyclophosphamide is and how it works

Mechanism of action

Cyclophosphamide belongs to a group of medicines called alkylating agents. After entering the body, it is converted (activated) mainly in the liver into active metabolites. These metabolites attach to DNA inside rapidly dividing cells. By damaging DNA, cyclophosphamide interferes with cell division, leading to cell death.

In cancer, this helps control or reduce tumour growth. In immune-mediated diseases, it also suppresses overactive immune responses by affecting rapidly proliferating immune cells.

Why it can be effective but also requires monitoring

The same properties that target abnormal or overactive cells can also affect normal tissues—particularly bone marrow and lining of the bladder—so blood tests and supportive measures (such as protective medication) are often used.

Pharmacokinetics (how the body handles the medicine)

Pharmacokinetics can vary between individuals and depend on the route and regimen. In general:

• Activation: Cyclophosphamide is a prodrug; it is metabolised in the liver to active and inactive metabolites.
• Distribution: Active compounds distribute throughout the body to reach target tissues.
• Elimination: Metabolites and unchanged drug are cleared mainly via the kidneys, so kidney function can affect exposure.
• Timing considerations: The effects on blood counts typically appear after treatment and may reach a low point (nadir) before recovery, which is why blood monitoring is scheduled.

A key safety concern is bladder toxicity, related to metabolites excreted in urine. Preventive strategies (for example, hydration and bladder-protective medication when appropriate) are often recommended by oncology teams.

Typical uses in the UK

Cyclophosphamide is used for different conditions, including both cancer and severe autoimmune or inflammatory diseases. Which regimen is used depends on the diagnosis, stage/severity, and your overall health.

Common indications

• Cancers (often in combination regimens), such as:
  • Breast cancer (selected regimens)
  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma
  • Multiple myeloma (selected regimens)
  • Some leukaemias and other haematological cancers
  • Selected solid tumours depending on protocol
• Severe immune system conditions where immunosuppression is needed, such as:
  • Severe vasculitis (e.g., certain ANCA-associated vasculitides)
  • Some cases of lupus and other autoimmune disorders

The exact indication and regimen will be determined by specialist teams such as oncology, haematology, rheumatology, or specialist immunology services.

How and when to take or receive cyclophosphamide

Timing

Cyclophosphamide scheduling varies widely. It may be given:

• In cycles (e.g., treatment on certain days followed by rest days)
• Once every few weeks in some regimens
• As a continuous or repeated course in certain protocols

Follow your healthcare team’s schedule exactly. If you miss a dose or your infusion is delayed, contact your clinic promptly for advice.

Administration route

• Tablets: typically taken at home according to the prescribed schedule.
• Injections/infusions: administered in hospital or infusion centres by trained professionals.

If you are using tablets, do not crush or open tablets unless your pharmacist or specialist has specifically instructed you to do so. Keep out of reach of children and handle according to safety guidance provided to you.

Food interactions

Cyclophosphamide can be taken with or without food, depending on the specific formulation and local instructions. However, it is important to follow the directions provided with your medicine.

Practical considerations:

• Consistency matters: Try to take it at the same times each day if your regimen is daily.
• Stomach upset: Nausea can occur. If food helps, taking with a light meal may be more comfortable (unless your clinician advised otherwise).
• Grapefruit and related foods: Because cyclophosphamide metabolism involves liver enzymes, it may be sensible to avoid strong grapefruit products unless your pharmacist confirms they are safe for your regimen.

Always check specific advice given to you, especially if you are taking other medicines that may affect liver enzymes.

Alcohol interactions

Cyclophosphamide can affect the liver and bone marrow. Alcohol may increase side effects such as nausea, dizziness, and fatigue, and may also add strain on the liver.

In general, it is recommended to:

• Avoid heavy or frequent alcohol intake during treatment.
• Discuss “safe” amounts with your clinician or pharmacist, particularly if you have liver problems, are on multiple medicines, or experience significant side effects.

Medicine interactions (what to tell your healthcare team)

Cyclophosphamide has important interactions with other medicines, mainly due to effects on liver metabolism and the immune system. Always provide your full list of medicines to your prescriber and pharmacist, including over-the-counter products and herbal supplements.

High-priority interactions to discuss

• Other chemotherapy or radiation: may increase risk of bone marrow suppression and infections.
• Immunosuppressants (including some biologics): may further increase infection risk.
• Warfarin or other anticoagulants: chemotherapy can change bleeding risk and may affect INR control—monitoring may be needed.
• Medicines affecting liver enzymes (examples include some antifungals, antivirals, and antibiotics): may alter cyclophosphamide activation and toxicity.
• Medicines that can affect kidney function: since metabolites are cleared by the kidneys, changes in kidney function may require dose adjustment.

Herbal and supplement caution

Herbal products (such as St John’s wort) can affect metabolism and may reduce safety or effectiveness. It is best to avoid non-essential supplements unless your pharmacist confirms they are safe.

Dosing and treatment planning

Cyclophosphamide dosing is individualised. It is commonly calculated using body surface area (BSA) and depends on the indication, regimen, and blood test results.

What influences your dose

• Diagnosis and treatment goal (cancer type, stage, immune condition severity)
• Body weight/BSA
• Blood counts (white blood cells and platelets)
• Liver and kidney function
• Prior treatments (previous chemotherapy/radiotherapy)
• Age and overall health

Typical dosing patterns (general overview)

Cyclophosphamide may be given:

• Intermittently on specific days within a cycle, or
• Daily for a set period in some immune-mediated regimens, or
• As part of combination chemotherapy with other agents (dose timing coordinated by the regimen).

Exact dosing schedules should be taken from your treatment plan and instructions provided by your specialist team.

Safety profile: side effects you should know

Cyclophosphamide can cause a range of side effects. Some are common and manageable, while others require urgent medical attention. Your care team will monitor you and may prescribe supportive medicines.

Common side effects

• Nausea and vomiting
• Loss of appetite
• Hair thinning or hair loss
• Fatigue
• Increased risk of infection (due to low white blood cells)
• Low blood counts (anaemia, low platelets)
• Sore mouth

Important risks (seek medical help)

• Infection: fever or feeling unwell can be serious. Contact urgent medical services or your oncology team promptly if you develop a fever or signs of infection.
• Bleeding: unusual bruising, black stools, blood in urine, or prolonged bleeding may indicate low platelets.
• Bladder irritation/toxicity: symptoms can include burning when passing urine, frequent urination, blood in urine, or pelvic pain. Report these urgently—bladder protection measures may be needed.
• Allergic reactions: rash, swelling, or breathing difficulty requires emergency assessment.
• Severe breathlessness or chest pain: seek urgent help immediately.

Long-term considerations

• Fertility effects: cyclophosphamide may affect fertility in both men and women.
• Pregnancy and contraception: it can cause harm to an unborn baby. Use effective contraception as advised by your specialist.
• Secondary cancers: there is a risk of malignancies later in life, depending on total exposure and individual factors.

Practical use tips (helping you cope safely)

Before starting treatment

• Have baseline blood tests and kidney/liver function checks.
• Ask your team what supportive medicines you may be offered (e.g., anti-sickness medicine, bladder protection, infection prevention strategies).
• Discuss fertility preservation options if relevant.
• Review your vaccination status with your clinician; some vaccines may not be suitable during treatment.

During treatment: daily safety habits

• Hydration: drink fluids as advised by your team to help reduce bladder exposure to metabolites.
• Monitoring: attend scheduled blood tests and appointments.
• Infection precautions: follow advice on hand hygiene, avoiding sick contacts, and seeking help early for fever.
• Oral care: keep teeth and mouth clean; ask about mouthwash or treatments for mouth soreness.
• Managing nausea: take prescribed anti-sickness medicines on time (often before symptoms start).
• Handling tablets: follow safety guidance to avoid exposure, particularly if you share a household with others.

When to call your healthcare team urgently

• Fever (especially if you feel unwell)
• Blood in urine or burning/painful urination
• Severe sore throat, mouth ulcers, or signs of infection
• Uncontrolled vomiting or inability to keep fluids down
• Unusual bleeding or bruising
• Shortness of breath, chest pain, or swelling of the face/lips

Alternative options

The best alternative depends on your diagnosis and stage, and whether cyclophosphamide is being used for cancer treatment or for immune suppression. In specialist care, other options may include:

For cancer regimens (examples)

• Other alkylating agents or chemotherapy classes depending on tumour type
• Targeted therapies (where appropriate)
• Immunotherapy (where appropriate)
• Radiotherapy or surgery in suitable cases

For immune-mediated diseases (examples)

• Other immunosuppressants (depending on condition and severity)
• Biologic therapies used in specific autoimmune diseases
• Less toxic maintenance strategies once control is achieved

Your specialist can explain why cyclophosphamide is recommended for your specific situation and what other options may be suitable.

UK market and legal context

In the United Kingdom, cyclophosphamide is a regulated medicine used in specialist settings. It is typically classed as a prescription-only medicine, and handling, supply, and administration are governed by UK medicines regulations and pharmacy standards.

Medicines in oncology and high-risk therapy require strict compliance with storage, labelling, patient counselling, and safe handling practices. If you order medicines online, reputable UK pharmacy services follow regulated processes to verify supply and ensure safe delivery.

Recent guidance and monitoring themes (UK)

While individual details vary by protocol and indication, UK clinical practice commonly emphasises:

• Close blood count monitoring during and after cycles
• Preventing infections with appropriate supportive measures when indicated
• Bladder protection strategies to reduce urinary toxicity risk
• Clear patient advice on urgent symptoms (fever, urinary symptoms, bleeding)
• Fertility and pregnancy counselling before treatment starts
• Medicines safety reviews to identify interactions with anticoagulants and enzyme-affecting drugs

For the latest, always follow the guidance provided by your treating team and local NHS protocols.

Delivery and availability (UK online pharmacy)

Cyclophosphamide availability can vary depending on formulation (tablets versus injection/infusion) and supply schedules. In many cases, injections/infusions are administered through hospitals or specialist centres rather than delivered to the home.

If tablets are supplied through an online pharmacy service, delivery typically follows regulated packaging and patient-safety labelling. Delivery times can vary by postcode and stock status, but reputable providers will display expected delivery options at checkout.

Storage at home (general guidance)

• Store according to the instructions on the pack label.
• Keep out of sight and reach of children.
• Do not use after the expiry date.
• If you are unsure about safe handling, ask your pharmacist for guidance.

FAQ — Cyclophosphamide

1) What is cyclophosphamide used for?

It is used in chemotherapy regimens to treat certain cancers and in some severe autoimmune or inflammatory conditions to suppress an overactive immune response. The exact reason for your treatment depends on your diagnosis.

2) How long does treatment last?

Cyclophosphamide is usually given in cycles. The total duration can range from weeks to months depending on response, blood counts, and side effects. Your specialist will set out the planned timetable.

3) What blood tests are monitored?

Typically, full blood counts and tests of kidney and liver function are monitored regularly. Your clinic may also monitor other parameters depending on your condition.

4) Can I take cyclophosphamide with food?

Many people can take it with or without food, but it depends on the regimen and formulation. Follow the directions you receive from your prescriber/pharmacist for your specific product.

5) Is it safe to drink alcohol during treatment?

Alcohol may increase certain side effects and may affect the liver. It’s best to avoid heavy drinking. Ask your healthcare team for personalised advice based on your health and other medicines.

6) What should I do if I forget a dose?

If you miss a dose, contact your healthcare team or pharmacist promptly for instructions. Do not double the dose unless they tell you to.

7) What are the warning signs of bladder problems?

Bladder irritation may include burning when passing urine, frequent urination, pelvic pain, or blood in the urine. Contact your treatment team urgently if these occur.

8) Will cyclophosphamide affect fertility?

It may affect fertility in both men and women. If you want children in the future, discuss fertility preservation options before treatment starts. Your team can advise on timing and options.

9) Can I drive while taking cyclophosphamide?

This depends on how you feel. Fatigue, dizziness, or nausea can occur. If you feel unwell or drowsy, avoid driving and ask your clinician for advice.

10) What vaccinations should I avoid?

Some vaccines (especially live vaccines) may be unsuitable during chemotherapy or immunosuppressive treatment. Discuss your vaccination plan with your specialist or GP.

11) Are there alternatives to cyclophosphamide?

Yes—depending on your condition, specialists may use different chemotherapy agents, targeted therapies, immunotherapies, or other immunosuppressants. Your doctor can explain which alternatives are appropriate for your diagnosis.

12) How do I reduce infection risk?

Follow your clinic’s advice. Common steps include regular handwashing, avoiding close contact with people who are unwell, monitoring for fever, and seeking prompt medical advice if you feel unwell.

Important reminder

This guide is designed to help you understand cyclophosphamide and how it may be used in the UK. It does not replace personalised medical advice. If you have questions about your specific regimen, side effects, or interactions with other medicines, speak to your specialist team or pharmacist.